Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a significant player in the medical device industry, has announced the award of restricted stock units (RSUs) to eleven new employees as …
TELA Bio Awards Stock Units to New Employees as Hiring Inducement Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently disclosed its first-quarter financial results for 2024, showcasing significant growth and strategic advancements. The company reported a revenue of $16.6 million, …
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) is slated to release its financial outcomes for the first quarter of 2024 on Thursday, May 9.
TELA Bio to Unveil First Quarter 2024 Financial Results Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leading innovator in the medical device sector, announced this week the U.S. launch of its latest product, OviTex IHR (Inguinal Hernia …
TELA Bio Launches Innovative Hernia Repair Device in the U.S. Market Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) this week announced the appointment of Howard N. Langstein, MD, FACS, as Vice President of Medical Affairs and Surgeon Strategy. This decision …
TELA Bio Appoints Esteemed Surgeon Dr. Howard N. Langstein as Vice President of Medical Affairs Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently revealed its financial performance for both the fourth quarter and the full calendar year ending on December 31, 2023. A cumulative …
TELA Bio Stands Tall With Consistent Growth, Novel Products, and a Promising Revenue Projection for 2024 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in the development of medical devices for soft tissue reconstruction, has made a significant stride in surgical innovation with the …
TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a key player in the development of innovative medical devices, has announced the sale of its distribution rights for the NIVIS Fibrillar …
TELA Bio Sells NIVIS Distribution Rights to MiMedx in Multi-Million Dollar Deal Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company, recenlty announced the granting of restricted stock units to five newly hired employees. The inducement grants cover …
TELA Bio Awards Restricted Stock Units to New Hires in Bid to Attract Top Talent Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a Pennsylvania-based leader in the medical technology industry, recently announced that it has granted restricted stock units (RSUs) covering 5,500 shares of …
TELA Bio’s Strategic Move: Offering Restricted Stock Units to New Hires Read More